Zurich Cantonal Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $610K | Buy |
9,652
+726
| +8% | +$45.9K | ﹤0.01% | 1532 |
|
2025
Q1 | $473K | Sell |
8,926
-108
| -1% | -$5.72K | ﹤0.01% | 1633 |
|
2024
Q4 | $506K | Sell |
9,034
-67
| -0.7% | -$3.75K | ﹤0.01% | 1619 |
|
2024
Q3 | $477K | Sell |
9,101
-8
| -0.1% | -$419 | ﹤0.01% | 1595 |
|
2024
Q2 | $374K | Sell |
9,109
-9
| -0.1% | -$370 | ﹤0.01% | 1688 |
|
2024
Q1 | $395K | Sell |
9,118
-63
| -0.7% | -$2.73K | ﹤0.01% | 1629 |
|
2023
Q4 | $422K | Buy |
9,181
+406
| +5% | +$18.7K | ﹤0.01% | 1616 |
|
2023
Q3 | $201K | Sell |
8,775
-174
| -2% | -$3.99K | ﹤0.01% | 1971 |
|
2023
Q2 | $148K | Sell |
8,949
-159
| -2% | -$2.62K | ﹤0.01% | 2118 |
|
2023
Q1 | $162K | Buy |
9,108
+2,229
| +32% | +$39.8K | ﹤0.01% | 2011 |
|
2022
Q4 | $200K | Buy |
6,879
+691
| +11% | +$20.1K | ﹤0.01% | 1818 |
|
2022
Q3 | $152K | Buy |
6,188
+2,446
| +65% | +$60.1K | ﹤0.01% | 1933 |
|
2022
Q2 | $16K | Hold |
3,742
| – | – | ﹤0.01% | 2820 |
|
2022
Q1 | $43K | Sell |
3,742
-1,656
| -31% | -$19K | ﹤0.01% | 2557 |
|
2021
Q4 | $54K | Sell |
5,398
-173
| -3% | -$1.73K | ﹤0.01% | 2712 |
|
2021
Q3 | $73K | Hold |
5,571
| – | – | ﹤0.01% | 2488 |
|
2021
Q2 | $109K | Buy |
5,571
+69
| +1% | +$1.35K | ﹤0.01% | 2177 |
|
2021
Q1 | $117K | Buy |
5,502
+1,760
| +47% | +$37.4K | ﹤0.01% | 2072 |
|
2020
Q4 | $111K | Hold |
3,742
| – | – | ﹤0.01% | 2169 |
|
2020
Q3 | $81K | Hold |
3,742
| – | – | ﹤0.01% | 2074 |
|
2020
Q2 | $83K | Buy |
3,742
+1,556
| +71% | +$34.5K | ﹤0.01% | 2032 |
|
2020
Q1 | $33K | Hold |
2,186
| – | – | ﹤0.01% | 2141 |
|
2019
Q4 | $50K | Buy |
+2,186
| New | +$50K | ﹤0.01% | 2153 |
|